Evert Bernd O, Araujo Julieta, Vieira-Saecker Ana M, de Vos Rob A I, Harendza Sigrid, Klockgether Thomas, Wüllner Ullrich
Department of Neurology, University of Bonn, 53105 Bonn, Germany.
J Neurosci. 2006 Nov 1;26(44):11474-86. doi: 10.1523/JNEUROSCI.2053-06.2006.
Ataxin-3 (AT3), the disease protein in spinocerebellar ataxia type 3 (SCA3), has been associated with the ubiquitin-proteasome system and transcriptional regulation. Here we report that normal AT3 binds to target DNA sequences in specific chromatin regions of the matrix metalloproteinase-2 (MMP-2) gene promoter and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones bound to the promoter. Both normal and expanded AT3 physiologically interacted with HDAC3 and NCoR in a SCA3 cell model and human pons tissue; however, normal AT3-containing protein complexes showed increased histone deacetylase activity, whereas expanded AT3-containing complexes had reduced deacetylase activity. Consistently, histone analyses revealed an increased acetylation of total histone H3 in expanded AT3-expressing cells and human SCA3 pons. Expanded AT3 lost the repressor function and displayed altered DNA/chromatin binding that was not associated with recruitment of HDAC3, NCoR, and deacetylation of the promoter, allowing aberrant MMP-2 transcription via the transcription factor GATA-2. For transcriptional repression normal AT3 cooperates with HDAC3 and requires its intact ubiquitin-interacting motifs (UIMs), whereas aberrant transcriptional activation by expanded AT3 is independent of the UIMs but requires the catalytic cysteine of the ubiquitin protease domain. These findings demonstrate that normal AT3 binds target promoter regions and represses transcription of a GATA-2-dependent target gene via formation of histone-deacetylating repressor complexes requiring its UIM-associated function. Expanded AT3 aberrantly activates transcription via its catalytic site and loses the ability to form deacetylating repressor complexes on target chromatin regions.
脊髓小脑共济失调3型(SCA3)的致病蛋白ataxin-3(AT3)与泛素-蛋白酶体系统及转录调控相关。我们在此报告,正常的AT3与基质金属蛋白酶-2(MMP-2)基因启动子特定染色质区域的靶DNA序列结合,并通过募集组蛋白去乙酰化酶3(HDAC3)、核受体共抑制因子(NCoR)以及使与启动子结合的组蛋白去乙酰化来抑制转录。在SCA3细胞模型和人类脑桥组织中,正常和扩增的AT3在生理上均与HDAC3和NCoR相互作用;然而,含正常AT3的蛋白复合物显示出增强的组蛋白去乙酰化酶活性,而含扩增AT3的复合物的去乙酰化酶活性则降低。一致地,组蛋白分析显示在表达扩增AT3的细胞和人类SCA3脑桥中,总组蛋白H3的乙酰化增加。扩增的AT3失去了抑制功能,并表现出DNA/染色质结合改变,这与HDAC3、NCoR的募集以及启动子的去乙酰化无关,从而通过转录因子GATA-2导致MMP-2异常转录。对于转录抑制,正常的AT3与HDAC3协同作用,并需要其完整的泛素相互作用基序(UIM),而扩增的AT3异常的转录激活则独立于UIM,但需要泛素蛋白酶结构域的催化半胱氨酸。这些发现表明,正常的AT3结合靶启动子区域,并通过形成需要其UIM相关功能的组蛋白去乙酰化抑制复合物来抑制GATA-2依赖的靶基因转录。扩增的AT3通过其催化位点异常激活转录,并失去在靶染色质区域形成去乙酰化抑制复合物的能力。